20 (AIDX) Accumulated Expenses (2024 - 2026)

20 posted quarterly Accumulated Expenses of $598335.0 for Q1 2026, down 23.86% on a QoQ basis from $785784.0 in Q4 2025.

20 (AIDX) has 3 years of Accumulated Expenses data on file, last reported at $598335.0 in Q1 2026.

  • For the quarter ending Q1 2026, Accumulated Expenses changed N/A year-over-year to $598335.0; the trailing twelve-month figure through Mar 2026 stood at $598335.0 (changed N/A YoY), and the FY2025 full-year result was $785784.0, up 126.7% from the prior year.
  • Accumulated Expenses for Q1 2026 stood at $598335.0, down from $785784.0 in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $785784.0 in Q4 2025 and bottomed at $346622.0 in Q4 2024.
  • The 3-year median for Accumulated Expenses is $598335.0 (2026), against an average of $576913.7.
  • Peak annual rise in Accumulated Expenses reached 126.7% in 2025, while the deepest fall reached 126.7% in 2025.
  • A 3-year view of Accumulated Expenses shows it stood at $346622.0 in 2024, then jumped by 126.7% to $785784.0 in 2025, then decreased by 23.86% to $598335.0 in 2026.
  • The last three Accumulated Expenses figures came in at $598335.0 (Q1 2026), $785784.0 (Q4 2025), and $346622.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 20 - - 62,884.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 598,335.00
Dec 31, 2025 785,784.00
Dec 31, 2024 346,622.00